Pfizer’s Drug Testing Strategy
James Ward
BUS 616 International Businesses
Instructor: Dr. Iweka
March 23, 2015
Pfizer 2
Pfizer’s Drug Testing Strategy in Nigeria
a) There are four different stages that a medicinal company goes through for it to carry a new medicinal product in the Western and United States industry. The first stage is the stage 0 where medication are rated in order to decide which medication has the biggest pharmacokinetic aspects in people so that it can be taken ahead for further growth. The second stage is Phase I where the medication is examined in people to evaluate aspects such as protection, pharmaco-kinetics and tolerability of the medication. Phase II is the third stage where assessments are conducted on larger categories to evaluate protection in a larger number of volunteers and sufferers, in Phase III there are randomised research on a larger team targeted at making a specified evaluation of the potency of the medication in evaluation with the current requirements (Hill, 2011). The last stage is the marketing monitoring test where a medication gets the permit to get into the industry especially in Western countries and US.
b) Pfizer were unethically by using an outbreak in the Africa Country of Nigeria and examining an expeCoca Colaental medication on kids. The organization was very opportunistic and therefore breached the required wellness and moral requirements by hurrying to manage the medication. The organization should have treaded more properly especially because an outbreak is a very delicate ailment and had the organization developed more properly, it would not have breached the moral requirements and the fatalities that were due to the analysis
References: Information retrieved from (http://data.worldbank.org/country/nigeria). Information retrieved from (http://www.bc.edu/content/dam/files/research_sites/agingandwork/pdf/publications/CP22_Workforce_Nigeria.pdf). Information retrieved from (http://www.g24.org/TGM/ongu0905.pdf).